Accendra Health appoints Gardner-Smith before Accendra Health stock update

Published on 10/20/2026 at 19:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gardner-Smith began as CEO on October 5, 2026. Accendra Health stock costs EUR 0.22 on October 20, 2026 at 7:35 p.m. CEST.

Leadership and operating figures

Accendra Health appointed Kenneth Gardner-Smith as chief executive officer effective October 5, 2026.
Second-quarter 2026 revenue reached USD 613.23 million, while the company reported a USD 89.07 million net loss.
Accendra Health stock was trading at EUR 0.22 at Lang & Schwarz on October 20, 2026 at 7:35 p.m. CEST.

ACH, US6907321029, Illustration mit AI erstellt.

Accendra Health (ISIN US6907321029) appointed Kenneth Gardner-Smith as chief executive officer effective October 5, 2026, according to MarketScreener. The leadership change comes as the company manages weaker quarterly profitability and a major operating transition. Accendra Health stock was trading at EUR 0.22 at Lang & Schwarz on October 20, 2026 at 7:35 p.m. CEST.

Leadership follows a difficult quarter

The second-quarter results put the management transition in financial context. Accendra Health generated USD 613.23 million of revenue in the quarter ended June 30, 2026, compared with USD 627.78 million in the first quarter. Net loss reached USD 89.07 million, or USD 1.16 per diluted share, versus a USD 6.47 million loss in the preceding quarter. The figures come from the standardized quarterly financial statements and are also reported by MarketBeat.

NYSE listing remains a key issue

Accendra Health operates in healthcare and medical distribution, with its Apria and Byram businesses serving patients who need home-based care. The company changed its name from Owens & Minor and began trading under the ACH ticker on the New York Stock Exchange on January 2, 2026, according to its investor-relations page.

On October 6, 2026, the company received a NYSE notice because its average closing price had remained below USD 1.00 for 30 trading days. The notice did not immediately delist the stock, and the company has six months to regain compliance, according to the release carried by MarketScreener.

What the operating figures mean

The quarter-to-quarter revenue decline was 2.32 percent, while the net loss widened by USD 82.60 million. Operating cash flow was negative USD 26.01 million in the second quarter, compared with negative USD 50.08 million in the first quarter. These figures leave execution, collections and cost control as the main operating variables for the new leadership team.

Stock trades at a low nominal level

On the NYSE, ACH was quoted at USD 0.24 on October 20, 2026 at 1:34 p.m. EDT. Accendra Health had a market capitalization of USD 18.4 million at the same market-data timestamp, while its reported 52-week range was USD 0.20 to USD 5.60.

The further course of trading is shown by the continuously updated real-time quote of Accendra Health stock.